Photo credit: commons.wikimedia.org

— Warren Buffett

A five-year holding period can be a useful lens for evaluating whether a stock has rewarded patient shareholders through business execution, multiple expansion, or both. In that context, Intuitive Surgical Inc (NASD: ISRG) provides a clear case study. A $10,000 investment in ISRG made on 10/19/2021 would have grown to $12,686.74 by 10/16/2026, based on the share prices shown below and assuming no dividends, since Intuitive Surgical does not pay a regular dividend.

ISRG Five-Year Return Summary

ISRG 5-Year Return Details
Start date:	10/19/2021	$10,000 10/19/2021   $12,686 10/16/2026
End date:	10/16/2026
Start price/share:	$336.30
End price/share:	$426.70
Starting shares:	29.74
Ending shares:	29.74
Dividends reinvested/share:	$0.00
Total return:	26.88%
Average annual return:	4.88%
Starting investment:	$10,000.00
Ending investment:	$12,686.74

Over the period, the position generated a 26.88% total return, equal to an annualized return of 4.88%. Because ISRG did not distribute dividends, the entire gain came from share-price appreciation. In practical terms, that means the investment outcome depended entirely on how the market reassessed Intuitive Surgical’s long-term earnings power, procedure growth, and installed-base economics over those five years.

What Drove the ISRG Return?

Intuitive Surgical is best known for its robotic-assisted surgery platform, with revenue historically supported by a combination of system placements, instruments and accessories used in procedures, and service revenue tied to its installed base. That business model matters when evaluating long-term returns. Capital equipment sales can be cyclical, but recurring revenue streams tied to utilization often provide greater resilience and visibility over time.

A five-year investment result in ISRG therefore reflects more than a change in the stock chart. It also captures the market’s view of several core variables:

• Procedure growth and adoption across surgical specialties
• Expansion of the installed base of robotic systems
• Utilization rates, which influence recurring instrument and accessory sales
• Margin trends, including manufacturing scale and operating leverage
• Valuation discipline at the point of purchase

That final point is especially important here. Intuitive Surgical has long been regarded as a high-quality medical technology company, but high-quality businesses do not always translate into high investment returns when purchased at elevated valuations. A moderate annualized return over a full five-year span can indicate that business quality remained intact while the entry price already reflected a significant portion of expected growth.

Key Takeaways From This $10,000 ISRG Investment

The numbers from this holding period can be summarized simply:

• Initial investment: $10,000.00
• Ending value: $12,686.74
• Total gain: $2,686.74
• Total return: 26.88%
• Annualized return: 4.88%
• Dividend contribution: None

For long-term investors, this illustrates a useful distinction: a strong underlying company and a strong stock return are related, but they are not identical. The entry point, the valuation multiple assigned by the market, and the pace of fundamental execution all shape the realized return.

Why the Five-Year Lens Matters

Shorter periods often say more about sentiment than about business value. A five-year window is long enough to include changing rate environments, shifts in risk appetite, and operational cycles in capital spending and healthcare utilization. For a company like Intuitive Surgical, which sits at the intersection of medical technology, hospital capital budgets, and recurring procedural demand, that broader time frame can provide a more balanced measure of shareholder outcomes.

The result shown above also highlights the importance of separating absolute returns from expectations. Turning $10,000 into $12,686.74 is a positive outcome, but whether it is compelling depends on the benchmark used, the risk assumed, and the valuation paid at the outset.

[These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

One more piece of investment wisdom to consider:
“Although it’s easy to forget sometimes, a share is not a lottery ticket… it’s part-ownership of a business.” — Peter Lynch